These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29617082)

  • 21. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N; Benning CM
    Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
    Yu HJ; Lin AT; Yang SS; Tsui KH; Wu HC; Cheng CL; Cheng HL; Wu TT; Chiang PH
    BJU Int; 2011 Dec; 108(11):1843-8. PubMed ID: 21592295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Takeshita H; Moriyama S; Arai Y; Washino S; Saito K; Chiba K; Horiuchi S; Noro A
    Low Urin Tract Symptoms; 2016 Jan; 8(1):38-43. PubMed ID: 26789541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of selective alpha-1-adrenergic receptor blockers on bladder weight.
    Egilmez T; Pourbagher MA; Guvel S; Kilinc F; Turunc T; Ozkardes H
    Urol Int; 2006; 76(1):42-50. PubMed ID: 16401920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.
    Kobayashi S; Tomiyama Y; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
    J Smooth Muscle Res; 2009 Aug; 45(4):187-95. PubMed ID: 19783871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of physician specialty and medical therapy for benign prostatic hyperplasia.
    Han LC; Kim SP; Gross CP; Ross JS; Van Houten HK; Smaldone MC; Krambeck AE; Shah ND
    Med Care; 2014 Feb; 52(2):128-36. PubMed ID: 24423810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K
    J Urol; 1998 Oct; 160(4):1358-67. PubMed ID: 9751354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.
    Erdoğru T; Ciftcioglu MA; Emreoglu I; Usta MF; Koksal T; Ozbilim G; Gulkesen KH; Baykara M
    Urol Int; 2002; 69(4):287-92. PubMed ID: 12444285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Miyakita H; Yokoyama E; Onodera Y; Utsunomiya T; Tokunaga M; Tojo T; Fujii N; Yanada S
    Int J Urol; 2010 Oct; 17(10):869-75. PubMed ID: 20735791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
    Liu Q; Zhu Y; Liu J; Qi J; Kang J
    Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factors determining treatment strategies for patients with benign prostatic hyperplasia. The DUO study].
    Fourcade RO; Picot MC; Gaudin AF; Texier N; Slama A
    Presse Med; 2007 May; 36(5 Pt 1):755-63. PubMed ID: 17329070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.
    Keledjian K; Borkowski A; Kim G; Isaacs JT; Jacobs SC; Kyprianou N
    Prostate; 2001 Jul; 48(2):71-8. PubMed ID: 11433417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.
    Kyprianou N; Jacobs SC
    Curr Urol Rep; 2000 Aug; 1(2):89-96. PubMed ID: 12084321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary assessment of Neck Circumference in Benign Prostatic Hyperplasia in Patients with Metabolic Syndrome.
    Akin Y; Gulmez H; Ates E; Gulum M; Savas M
    Int Braz J Urol; 2017; 43(1):95-103. PubMed ID: 28124531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized crossover study comparing patient preference for tamsulosin and silodosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Watanabe T; Ozono S; Kageyama S
    J Int Med Res; 2011; 39(1):129-42. PubMed ID: 21672315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of alpha blockers in treatment of premature ejaculation: a pilot clinical trial.
    Akin Y; Gulmez H; Ates M; Bozkurt A; Nuhoglu B
    Iran Red Crescent Med J; 2013 Oct; 15(10):e13805. PubMed ID: 24693363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals.
    Senkul T; Yilmaz O; Iseri C; Adayener C; Akyol I; Ates F
    Int Urol Nephrol; 2008; 40(3):663-6. PubMed ID: 18080839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
    Yokoyama T; Hara R; Fukumoto K; Fujii T; Jo Y; Miyaji Y; Nagai A; Sone A
    Int J Urol; 2011 Mar; 18(3):225-30. PubMed ID: 21272091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.